Anti-CD19 CAR T-Cell Therapy in Acute Lymphocytic Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Acute Lymphocytic Leukaemia: A Systematic Review and Meta-Analysis
Lancet Haematol 2020 Nov 01;7(11)e816-e826, T Anagnostou, IB Riaz, SK Hashmi, MH Murad, SS KenderianFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.